Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colectomy | 6 | 2021 | 30 | 1.890 |
Why?
|
| Surgical Wound Infection | 4 | 2022 | 99 | 1.870 |
Why?
|
| Laparoscopy | 6 | 2021 | 184 | 1.540 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2020 | 21 | 1.340 |
Why?
|
| Mesocolon | 4 | 2019 | 5 | 1.300 |
Why?
|
| Developed Countries | 2 | 2019 | 6 | 1.140 |
Why?
|
| Developing Countries | 2 | 2019 | 57 | 1.100 |
Why?
|
| Rectal Neoplasms | 3 | 2021 | 19 | 0.990 |
Why?
|
| Anastomosis, Surgical | 3 | 2019 | 58 | 0.870 |
Why?
|
| Colonic Neoplasms | 3 | 2021 | 70 | 0.850 |
Why?
|
| Lutetium | 1 | 2024 | 3 | 0.850 |
Why?
|
| Radioisotopes | 1 | 2024 | 8 | 0.850 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2024 | 8 | 0.850 |
Why?
|
| Phenylthiohydantoin | 1 | 2024 | 8 | 0.840 |
Why?
|
| Nitriles | 1 | 2024 | 24 | 0.840 |
Why?
|
| Antigens, Surface | 1 | 2024 | 25 | 0.840 |
Why?
|
| Prostate-Specific Antigen | 1 | 2024 | 59 | 0.830 |
Why?
|
| Benzamides | 1 | 2024 | 60 | 0.830 |
Why?
|
| Up-Regulation | 1 | 2024 | 193 | 0.800 |
Why?
|
| Pancreaticoduodenectomy | 2 | 2020 | 23 | 0.770 |
Why?
|
| Colostomy | 2 | 2019 | 6 | 0.730 |
Why?
|
| Ligation | 3 | 2019 | 64 | 0.730 |
Why?
|
| Laparotomy | 2 | 2019 | 30 | 0.720 |
Why?
|
| Abdomen | 2 | 2018 | 44 | 0.670 |
Why?
|
| Telemedicine | 1 | 2022 | 122 | 0.650 |
Why?
|
| Colon, Ascending | 2 | 2019 | 2 | 0.630 |
Why?
|
| Pancreatic Fistula | 1 | 2019 | 4 | 0.620 |
Why?
|
| Ceftriaxone | 1 | 2019 | 15 | 0.620 |
Why?
|
| Metronidazole | 1 | 2019 | 14 | 0.610 |
Why?
|
| Hemorrhoids | 1 | 2019 | 1 | 0.610 |
Why?
|
| Crohn Disease | 2 | 2019 | 31 | 0.580 |
Why?
|
| Neuroendocrine Tumors | 1 | 2019 | 19 | 0.580 |
Why?
|
| Emergency Treatment | 1 | 2019 | 37 | 0.570 |
Why?
|
| Checklist | 1 | 2019 | 39 | 0.570 |
Why?
|
| Surgical Flaps | 2 | 2018 | 76 | 0.560 |
Why?
|
| Hernia, Femoral | 1 | 2017 | 1 | 0.530 |
Why?
|
| Humans | 22 | 2024 | 32282 | 0.530 |
Why?
|
| Cross Infection | 1 | 2018 | 57 | 0.530 |
Why?
|
| Intestinal Obstruction | 1 | 2017 | 12 | 0.520 |
Why?
|
| Indocyanine Green | 1 | 2017 | 14 | 0.520 |
Why?
|
| Coloring Agents | 1 | 2017 | 32 | 0.520 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 324 | 0.510 |
Why?
|
| Reoperation | 1 | 2018 | 252 | 0.510 |
Why?
|
| Postoperative Complications | 4 | 2021 | 823 | 0.510 |
Why?
|
| Cohort Studies | 5 | 2022 | 1840 | 0.490 |
Why?
|
| Aged | 9 | 2024 | 10263 | 0.430 |
Why?
|
| Male | 13 | 2024 | 19441 | 0.420 |
Why?
|
| Prospective Studies | 4 | 2020 | 2316 | 0.400 |
Why?
|
| Treatment Outcome | 6 | 2024 | 3416 | 0.380 |
Why?
|
| Female | 12 | 2021 | 19945 | 0.350 |
Why?
|
| Middle Aged | 8 | 2024 | 11851 | 0.340 |
Why?
|
| Adenocarcinoma | 3 | 2020 | 298 | 0.330 |
Why?
|
| Adult | 7 | 2022 | 9259 | 0.300 |
Why?
|
| Retrospective Studies | 5 | 2024 | 3626 | 0.290 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 3900 | 0.230 |
Why?
|
| Ligands | 1 | 2024 | 90 | 0.210 |
Why?
|
| Aftercare | 1 | 2022 | 35 | 0.180 |
Why?
|
| Polyps | 1 | 2021 | 9 | 0.180 |
Why?
|
| Pancreatic Diseases | 1 | 2021 | 21 | 0.180 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 2240 | 0.180 |
Why?
|
| Pancreatectomy | 1 | 2021 | 25 | 0.180 |
Why?
|
| Risk Factors | 2 | 2020 | 3934 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2022 | 204 | 0.170 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2020 | 7 | 0.160 |
Why?
|
| Duodenal Neoplasms | 1 | 2020 | 7 | 0.160 |
Why?
|
| Survival Rate | 2 | 2020 | 893 | 0.160 |
Why?
|
| Cephalexin | 1 | 2019 | 2 | 0.160 |
Why?
|
| Clostridium Infections | 1 | 2019 | 10 | 0.150 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 853 | 0.150 |
Why?
|
| Organizational Policy | 1 | 2019 | 20 | 0.150 |
Why?
|
| Infertility, Female | 1 | 2019 | 6 | 0.150 |
Why?
|
| Health Status | 1 | 2021 | 355 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2019 | 20 | 0.150 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 40 | 0.150 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2019 | 17 | 0.150 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 489 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 28 | 0.150 |
Why?
|
| World Health Organization | 1 | 2019 | 17 | 0.150 |
Why?
|
| Emergencies | 1 | 2019 | 45 | 0.140 |
Why?
|
| Suture Techniques | 1 | 2019 | 60 | 0.140 |
Why?
|
| Infant, Newborn | 1 | 2020 | 666 | 0.140 |
Why?
|
| Omentum | 1 | 2018 | 25 | 0.140 |
Why?
|
| Incidence | 2 | 2019 | 1241 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2018 | 45 | 0.130 |
Why?
|
| Infant | 1 | 2020 | 1010 | 0.130 |
Why?
|
| Anal Canal | 1 | 2018 | 34 | 0.130 |
Why?
|
| Peritoneum | 1 | 2017 | 32 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 651 | 0.130 |
Why?
|
| Diet | 1 | 2019 | 383 | 0.130 |
Why?
|
| Child, Preschool | 1 | 2020 | 1233 | 0.130 |
Why?
|
| Logistic Models | 1 | 2019 | 743 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 219 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 388 | 0.120 |
Why?
|
| Cecal Neoplasms | 1 | 2016 | 2 | 0.120 |
Why?
|
| Mesentery | 1 | 2016 | 6 | 0.120 |
Why?
|
| Infrared Rays | 1 | 2016 | 17 | 0.120 |
Why?
|
| Adolescent | 2 | 2020 | 3519 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2016 | 113 | 0.110 |
Why?
|
| Child | 1 | 2020 | 2435 | 0.110 |
Why?
|
| Lymph Node Excision | 2 | 2016 | 94 | 0.060 |
Why?
|
| Young Adult | 2 | 2020 | 2649 | 0.050 |
Why?
|
| Morbidity | 1 | 2021 | 98 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2021 | 69 | 0.040 |
Why?
|
| Hand Strength | 1 | 2021 | 98 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 106 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 553 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 129 | 0.040 |
Why?
|
| Colitis, Ulcerative | 1 | 2019 | 24 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 475 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 161 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 50 | 0.030 |
Why?
|
| Colon, Transverse | 1 | 2016 | 1 | 0.030 |
Why?
|
| Mesenteric Veins | 1 | 2016 | 10 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 168 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1534 | 0.030 |
Why?
|
| Dissection | 1 | 2016 | 16 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 321 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 1425 | 0.030 |
Why?
|
| United States | 1 | 2021 | 4072 | 0.020 |
Why?
|